8329 — Shenzhen Neptunus Interlong Bio-technique Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Market Cap
HK$248.34m
Enterprise Value
HK$48.66m
Revenue
CNY1.06bn

Annual balance sheet for Shenzhen Neptunus Interlong Bio-technique Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	384	416	311	350	382
Net Total Accounts Receivable
Net Total Receivables	258	214	231	277	290
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	806	809	740	895	921
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	215	220	309	301	286
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,124	1,121	1,308	1,448	1,416
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	244	212	335	413	366
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	367	327	478	564	507
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	757	794	830	884	908
Total Liabilities & Shareholders' Equity	1,124	1,121	1,308	1,448	1,416
Total Common Shares Outstanding